Kiave Yune Ho Wang Yin, PhD, Chief Business Officer at TransCure bioServices explores how humanized mouse models can be used to develop more relevant preclinical studies for IBD treatments and ultimately increase the likelihood of a treatment's success in clinical trials.  Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis (UC), are a global health […]